H de Thé1, M K Chelbi-Alix. Show Affiliations » 1. CNRS UPR 9051 Hôpital St. Louis 1, avenue C. Vellefaux 75475 Paris Cedex 10, France.
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Agents/therapeutic useArsenic TrioxideArsenicals/therapeutic useCell Differentiation/drug effectsCell Nucleus/metabolismCellular Senescence/geneticsHumansInclusion Bodies/metabolismLeukemia, Promyelocytic, Acute/drug therapyLeukemia, Promyelocytic, Acute/geneticsLeukemia, Promyelocytic, Acute/metabolismMultigene FamilyNeoplasm Proteins/geneticsNeoplasm Proteins/metabolismOncogene Proteins, Fusion/geneticsOncogene Proteins, Fusion/metabolismOxides/therapeutic useReceptors, Retinoic Acid/drug effectsReceptors, Retinoic Acid/geneticsReceptors, Retinoic Acid/metabolismRetinoic Acid Receptor alphaTretinoin/therapeutic use
Substances: See more » Antineoplastic AgentsArsenicalsNeoplasm ProteinsOncogene Proteins, FusionOxidesRARA protein, humanReceptors, Retinoic AcidRetinoic Acid Receptor alphapromyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinTretinoinArsenic Trioxide
Year: 2001 PMID: 11704841 DOI: 10.1038/sj.onc.1204851
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867